International Stem Cell Corporation
ISCO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.2M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.20 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.05 |
| Beta | -0.05 |
| Outstanding Shares | 8,004,389 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -2.39 |
|---|---|
| PEG | 1.54 |
| Price to Sales | 0.15 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About International Stem Cell Corporation
33 employees
CEO: Andrey Semechkin
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings ...